Renaissance Technologies LLC Sells 50,600 Shares of Veru Inc (NASDAQ:VERU)

Renaissance Technologies LLC reduced its holdings in shares of Veru Inc (NASDAQ:VERU) by 29.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 120,800 shares of the company’s stock after selling 50,600 shares during the period. Renaissance Technologies LLC owned about 0.23% of Veru worth $244,000 at the end of the most recent quarter.

Separately, ACG Wealth purchased a new stake in Veru during the 2nd quarter worth approximately $156,000. 9.73% of the stock is currently owned by institutional investors.

NASDAQ VERU traded up $0.02 on Monday, hitting $1.52. 62,627 shares of the stock were exchanged, compared to its average volume of 120,499. The company has a quick ratio of 0.80, a current ratio of 1.01 and a debt-to-equity ratio of 0.12. Veru Inc has a fifty-two week low of $0.90 and a fifty-two week high of $2.37. The stock has a market capitalization of $82.93 million, a PE ratio of -6.08 and a beta of 0.87.

Several brokerages recently weighed in on VERU. Zacks Investment Research raised shares of Veru from a “sell” rating to a “buy” rating and set a $1.50 target price on the stock in a research note on Wednesday, October 17th. ValuEngine raised shares of Veru from a “hold” rating to a “buy” rating in a research note on Wednesday, August 15th. Maxim Group reaffirmed a “buy” rating and set a $10.00 target price on shares of Veru in a research note on Monday, August 27th. Finally, HC Wainwright reiterated a “buy” rating and set a $5.00 price target on shares of Veru in a report on Wednesday, August 15th. Five investment analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and an average price target of $5.50.

TRADEMARK VIOLATION NOTICE: “Renaissance Technologies LLC Sells 50,600 Shares of Veru Inc (NASDAQ:VERU)” was posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at

Veru Profile

Veru Inc operates as a urology and oncology biopharmaceutical company. The company operates through two segments, Commercial; and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.

See Also: Exchange-Traded Funds (ETFs)

Institutional Ownership by Quarter for Veru (NASDAQ:VERU)

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with's FREE daily email newsletter.

Leave a Reply